{
    "organizations": [],
    "uuid": "d7e04656a51475fa707ed3662e36ad8ded1caa47",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oragenics-texas-am-university-syst/brief-oragenics-texas-am-university-system-granted-u-s-patent-for-lantibiotic-mu1140-idUSFWN1SU0Y5",
    "ord_in_thread": 0,
    "title": "BRIEF-Oragenics, Texas A&M University System Granted U.S. Patent For Lantibiotic MU1140",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - Oragenics Inc:\n* ORAGENICS, INC. AND TEXAS A&M UNIVERSITY SYSTEM GRANTED U.S. PATENT FOR LANTIBIOTIC MU1140\n* ORAGENICS INC - AMONG OTHER THINGS, PATENT COVERS UNIQUE VARIANTS OF LANTIBIOTIC 1140 (MU1140) Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-24T02:27:00.000+03:00",
    "crawled": "2018-05-24T20:45:52.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oragenics",
        "inc",
        "oragenics",
        "texas",
        "university",
        "system",
        "granted",
        "patent",
        "lantibiotic",
        "mu1140",
        "oragenics",
        "inc",
        "among",
        "thing",
        "patent",
        "cover",
        "unique",
        "variant",
        "lantibiotic",
        "mu1140",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}